Evidence map›Paper›PMID 31105688›Full record

ArticleFrontiers in immunology2019

Envelope-Specific Recognition Patterns of HIV Vaccine-Induced IgG Antibodies Are Linked to Immunogen Structure and Sequence.

Yuka Nadai, Kathrin Held, Sarah Joseph, Mohamed I M Ahmed, Verena S Hoffmann, David Peterhoff, Marco Missanga, Asli Bauer, Agricola Joachim, Ulf Reimer and 15 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 4 countries.

Yuka NadaiDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
Kathrin HeldDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
Sarah JosephMRC Clinical Trials Unit at UCL, London, United Kingdom.
Mohamed I M AhmedDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
Verena S HoffmannDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
David PeterhoffInstitute of Medical Microbiology and Hygiene, University Regensburg, Regensburg, Germany.
Marco MissangaNIMR-Mbeya Medical Research Center, Mbeya, Tanzania.
Asli BauerDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
Agricola JoachimMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Ulf ReimerJPT Peptide Technologies, Berlin, Germany.
Johannes ZerweckJPT Peptide Technologies, Berlin, Germany.
Sheena McCormackMRC Clinical Trials Unit at UCL, London, United Kingdom.
Alethea V CopeDepartment of Medicine, Imperial College London, London, United Kingdom.
Roger TatoudDepartment of Medicine, Imperial College London, London, United Kingdom.
Robin J ShattockDepartment of Medicine, Imperial College London, London, United Kingdom.
Merlin Lee RobbUS Military HIV Research Program, Silver Spring, MD, United States.
Eric G SandstroemDepartment of Clinical Science and Education, Karolinska Institutet at Södersjukhuset, Stockholm, Sweden.
Michael HoelscherDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
Leonard MabokoNIMR-Mbeya Medical Research Center, Mbeya, Tanzania.
Muhammad BakariMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Arne KroidlDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
Ralf WagnerInstitute of Medical Microbiology and Hygiene, University Regensburg, Regensburg, Germany.
Jonathan WeberDepartment of Medicine, Imperial College London, London, United Kingdom.
Georgios PollakisInstitute of Global Health (CIMI), University of Liverpool, Liverpool, United Kingdom.
Christof GeldmacherDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
Ludwig-Maximilians-Universität München · DEImperial College London · GBGerman Center for Infection Research · DEInstitute of Medical Microbiology and Hygiene · DEMRC Clinical Trials Unit at UCL · GBMuhimbili University of Health and Allied Sciences · TZKarolinska Institutet · SELMU Klinikum · DEUniversity of Liverpool · GB

Funding

Medical Research Council G1001784Medical Research Council MC_U122861400Medical Research Council MC_UU_12023/23Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAIDS VaccinesAmino Acid MotifsAmino Acid SequenceAntibody SpecificityAntigens, Viralenv Gene Products, Human Immunodeficiency VirusEpitope MappingEpitopesFemaleHIVHIV AntibodiesHIV InfectionsHumansImmunization ScheduleAIDS VaccinesAntigens, Viralenv Gene Products, Human Immunodeficiency VirusEpitopesHIV AntibodiesImmunoglobulin Genvelope-specific antibodiesepitope variant recognitionHIVimmunogen sequenceimmunogen structurevaccine

Identifiers

PMID31105688
PMCPMC6492543
OpenAlexW2940880353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.